926-share sale notice for Aclaris Therapeutics (NASDAQ: ACLS) via Form 144
Rhea-AI Filing Summary
ACLS filed a Form 144 notice reporting a proposed sale of 926 common shares related to restricted stock vesting under a registered plan. The filing shows the vesting date as 05/15/2026 and the Form 144 entry date as 05/22/2026.
Positive
- None.
Negative
- None.
Insights
Routine resale notice for a small block of vested restricted stock.
The filing lists a proposed sale of 926 common shares tied to restricted stock vesting under a registered plan, with a vesting date of 05/15/2026. This is a broker-handled resale notice rather than a corporate financing action.
Timing and execution details are not provided in the excerpt; subsequent SEC filings or trade records would show whether and when the shares were actually sold.
Key Figures
Form 144 reported shares: 926 shares
Vesting date: 05/15/2026
Form 144 entry date: 05/22/2026
3 metrics
Form 144 reported shares
926 shares
Proposed sale tied to restricted stock vesting
Vesting date
05/15/2026
Restricted stock vesting under a registered plan
Form 144 entry date
05/22/2026
Date shown in the filing excerpt
Key Terms
Form 144, restricted stock vesting, registered plan
3 terms
Form 144 regulatory
"Common | Morgan Stanley Smith Barney LLC Executive Financial Services ... 05/22/2026"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
restricted stock vesting financial
"Restricted stock vesting under a registered plan | Issuer"
Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.
registered plan regulatory
"Restricted stock vesting under a registered plan"
A registered plan is a savings or investment account that a government recognizes for special tax treatment and rules, such as limits on how much you can put in and conditions for withdrawals. For investors it matters because those rules change how much of your gains are taxed, how quickly your money can be accessed and what strategies make sense — like a labeled jar that gives tax breaks but comes with rules about when and how you can take the money out.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does the ACLS Form 144 filing report?
It reports a proposed sale of 926 common shares tied to restricted stock vesting. The filing lists a vesting date of 05/15/2026 and an entry/date of 05/22/2026, indicating a broker-handled resale notice under a registered plan.
Does the ACLS filing show who will receive proceeds?
The excerpt does not name a proceeds recipient beyond indicating the shares are from the issuer under a registered plan. The filing lists the broker as Morgan Stanley Smith Barney LLC Executive Financial Services, which handled the Form 144 notice.
What role does Morgan Stanley Smith Barney LLC play in the filing?
The excerpt lists Morgan Stanley Smith Barney LLC Executive Financial Services alongside the securities line, indicating the broker handling the Form 144 notice for the proposed sale of 926 shares on 05/22/2026.